Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


AstraZeneca Blames Germany’s Tender System For Influenza Vaccine Shortages

This article was originally published in The Pink Sheet Daily

Executive Summary

AstraZeneca says that shortages of influenza vaccines in Germany are a direct result of the tendering process there, which has blocked the firm’s Fluenz nasal spray product from being prescribed in several federal states.

You may also be interested in...

German Vaccine Reforms Offer Multiple Tenders; Firms Want Purchase Guarantees

Government argues that shortages can be avoided by contracting with multiple manufacturers, but industry says changes do not go far enough, and is asking for sales assurances.

Germany’s Vaccine Industry In Danger Of Disappearing, Says GSK

GSK believes detrimental government policies such as reference pricing and tendering in the vaccines sector are threatening this part of the pharmaceutical industry, and patient health.

Germany’s New Non-Substitution Drug List No Big Bang For Pharma

Germany will have its first list of non-substitutable pharmaceuticals since the introduction of discount contracts, but the benefit it offers to original product manufacturers will be severely limited.

Related Content


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts